Rolando B Rodriguez
CIK 1197432 · View on SEC EDGAR ↗
First SEC filing: Feb. 28, 2018 · Latest: Feb. 28, 2018
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 31, 2018 | MCS | S | 4,125 | $38.62 | $159,308 | 32,850 Direct | -11.16% | Disposed | -20.7% (price as of 2026-08-20) |
| May 30, 2018 | MCS | S | 12,000 | $31.31 | $375,720 | 43,100 Direct | -21.78% | Disposed | -2.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 1, 2018 | MCS | Stock Option (right to buy) (granted 7/28/15) | Common Stock (389) | $20.26 | July 28, 2025 | 389 | Disposed |
| Aug. 1, 2018 | MCS | Stock Option (right to buy) (granted 7/29/14) | Common Stock (3,600) | $18.34 | July 29, 2024 | 3,600 | Disposed |
| July 31, 2018 | MCS | Stock Option (right to buy) (granted 7/30/13) | Common Stock (2,000) | $13.04 | July 30, 2023 | 2,000 | Disposed |
| June 6, 2018 | MCS | Stock Option (right to buy) (granted 7/28/15) | Common Stock (389) | $20.26 | July 28, 2025 | 389 | Disposed |
| June 6, 2018 | MCS | Stock Option (right to buy) (granted 7/29/14) | Common Stock (7,630) | $18.34 | July 29, 2024 | 7,630 | Disposed |
| Feb. 27, 2018 | MCS | Stock Option (right to buy) (granted 2/27/18) | Common Stock (34,000) | $27.00 | Feb. 27, 2028 | 34,000 | Acquired |
| Aug. 4, 2017 | MCS | Stock Option (right to buy) (granted 7/30/13) | Common Stock (2,000) | $13.04 | July 30, 2023 | 2,000 | Disposed |
| Feb. 28, 2017 | MCS | Stock Option (right to buy) (granted 3/1/15) | Common Stock (20,000) | $31.20 | Feb. 28, 2027 | 20,000 | Acquired |
| Aug. 23, 2016 | MCS | Stock Option (right to buy) (granted 7/30/13) | Common Stock (6,000) | $13.04 | July 30, 2023 | 6,000 | Disposed |
| March 1, 2016 | MCS | Stock Option (right to buy) (granted 3/1/15) | Common Stock (12,500) | $18.68 | March 1, 2026 | 12,500 | Acquired |
| July 28, 2015 | MCS | Stock Option (right to buy) (granted 7/28/15) | Common Stock (20,000) | $20.26 | July 28, 2025 | 20,000 | Acquired |
| July 28, 2015 | MCS | Stock Option (right to buy) (granted 7/28/15) | Common Stock (20,000) | $20.26 | July 28, 2025 | 20,000 | Acquired |
| July 29, 2014 | MCS | Stock Option (right to buy) (granted 7/29/14) | Common Stock (18,000) | $18.34 | July 29, 2024 | 18,000 | Acquired |
| July 30, 2013 | MCS | Stock Option (right to buy) (granted 7/30/13) | Common Stock (10,000) | $13.04 | July 30, 2023 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MCS
Chairman, President and CEO of Marcus Theatres Corporation| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $591,961 | $60,000 | $285,110 | $401,200 | $198,202 | $465,444 | $43,603 | $2,045,520 |
| 2018 | $544,969 | — | $287,100 | $296,140 | $648,980 | $182,919 | $42,116 | $2,002,224 |
| 2017 | $535,029 | — | $178,200 | $268,000 | $484,406 | $277,581 | $25,910 | $1,769,126 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.